 |
PDBsum entry 4w1v
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
4w1v
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase/transferase inhibitor
|
 |
|
Title:
|
 |
Crystal structure of 7,8-diaminopelargonic acid synthase (bioa) from mycobacterium tuberculosis, complexed with a thiazole inhibitor
|
|
Structure:
|
 |
Adenosylmethionine-8-amino-7-oxononanoate aminotransferase. Chain: a, b. Synonym: 7,8-diamino-pelargonic acid aminotransferase,dapa aminotransferase,8-diaminononanoate synthase,dans,diaminopelargonic acid synthase. Engineered: yes
|
|
Source:
|
 |
Mycobacterium tuberculosis. Organism_taxid: 83331. Strain: cdc 1551 / oshkosh. Gene: bioa, mt1619. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Resolution:
|
 |
|
2.24Å
|
R-factor:
|
0.172
|
R-free:
|
0.210
|
|
|
Authors:
|
 |
B.C.Finzel,R.Dai
|
|
Key ref:
|
 |
S.W.Park
et al.
(2015).
Target-based identification of whole-cell active inhibitors of biotin biosynthesis in Mycobacterium tuberculosis.
Chem Biol,
22,
76-86.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
13-Aug-14
|
Release date:
|
04-Feb-15
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P9WQ80
(BIOA_MYCTO) -
Adenosylmethionine-8-amino-7-oxononanoate aminotransferase from Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
437 a.a.
425 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.6.1.62
- adenosylmethionine--8-amino-7-oxononanoate transaminase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
(8S)-8-amino-7-oxononanoate + S-adenosyl-L-methionine = S-adenosyl-4- methylsulfanyl-2-oxobutanoate + (7R,8S)-7,8-diammoniononanoate
|
 |
 |
 |
 |
 |
(8S)-8-amino-7-oxononanoate
|
+
|
S-adenosyl-L-methionine
|
=
|
S-adenosyl-4- methylsulfanyl-2-oxobutanoate
|
+
|
(7R,8S)-7,8-diammoniononanoate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
Pyridoxal 5'-phosphate
|
 |
 |
 |
 |
 |
Pyridoxal 5'-phosphate
Bound ligand (Het Group name =
PLP)
matches with 93.75% similarity
|
|
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Chem Biol
22:76-86
(2015)
|
|
PubMed id:
|
|
|
|
|
| |
|
Target-based identification of whole-cell active inhibitors of biotin biosynthesis in Mycobacterium tuberculosis.
|
|
S.W.Park,
D.E.Casalena,
D.J.Wilson,
R.Dai,
P.P.Nag,
F.Liu,
J.P.Boyce,
J.A.Bittker,
S.L.Schreiber,
B.C.Finzel,
D.Schnappinger,
C.C.Aldrich.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Biotin biosynthesis is essential for survival and persistence of Mycobacterium
tuberculosis (Mtb) in vivo. The aminotransferase BioA, which catalyzes the
antepenultimate step in the biotin pathway, has been established as a promising
target due to its vulnerability to chemical inhibition. We performed
high-throughput screening (HTS) employing a fluorescence displacement assay and
identified a diverse set of potent inhibitors including many diversity-oriented
synthesis (DOS) scaffolds. To efficiently select only hits targeting biotin
biosynthesis, we then deployed a whole-cell counterscreen in biotin-free and
biotin-containing medium against wild-type Mtb and in parallel with isogenic
bioA Mtb strains that possess differential levels of BioA expression. This
counterscreen proved crucial to filter out compounds whose whole-cell activity
was off target as well as identify hits with weak, but measurable whole-cell
activity in BioA-depleted strains. Several of the most promising hits were
cocrystallized with BioA to provide a framework for future structure-based drug
design efforts.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |